Cycrin

   
Google
 
Web NewDrugInformation.com

Cycrin


Drug - Cycrin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Medroxyprogesterone Acetate
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Medroxyprogesterone Acetate. May repeat for multiple part products.

Applicant - ESI
The firm name holding legal responsibility for Cycrin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 081240
The FDA assigned number to Cycrin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cycrin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 30, 1992
The date Cycrin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cycrin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Cycrin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Esi Pharmacal
The full name of the firm holding legal responsibility for the new application of Cycrin.

Cycrin